Gabriel Kamenský

3.1k total citations
10 papers, 648 citations indexed

About

Gabriel Kamenský is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Gabriel Kamenský has authored 10 papers receiving a total of 648 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 2 papers in Surgery and 1 paper in Molecular Biology. Recurrent topics in Gabriel Kamenský's work include Acute Myocardial Infarction Research (4 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers) and Atrial Fibrillation Management and Outcomes (3 papers). Gabriel Kamenský is often cited by papers focused on Acute Myocardial Infarction Research (4 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers) and Atrial Fibrillation Management and Outcomes (3 papers). Gabriel Kamenský collaborates with scholars based in Slovakia, Sweden and France. Gabriel Kamenský's co-authors include Josép Brugada, Greg Flaker, Sean Yang, Salim Yusuf, Paul Reilly, Jonas Oldgren, Rangadham Nagarakanti, Michael D. Ezekowitz, Michael R. Chernick and Amit Parekh and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Journal of the American Heart Association.

In The Last Decade

Gabriel Kamenský

10 papers receiving 622 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gabriel Kamenský Slovakia 6 514 188 132 67 42 10 648
Christine Teutsch United States 15 764 1.5× 228 1.2× 31 0.2× 77 1.1× 119 2.8× 44 840
Chenxi Jiang China 16 753 1.5× 76 0.4× 69 0.5× 39 0.6× 72 1.7× 104 892
M. Alasady Australia 13 1.5k 3.0× 97 0.5× 133 1.0× 36 0.5× 77 1.8× 32 1.6k
Étienne Marchand France 10 290 0.6× 33 0.2× 129 1.0× 35 0.5× 68 1.6× 27 525
В. А. Марков Russia 7 736 1.4× 272 1.4× 122 0.9× 41 0.6× 26 0.6× 38 814
Xinshun Gu China 15 279 0.5× 65 0.3× 189 1.4× 74 1.1× 30 0.7× 51 661
Mikhail S. Dzeshka Belarus 9 625 1.2× 66 0.4× 79 0.6× 111 1.7× 50 1.2× 26 768
Michael Stuart Garfinkle Canada 4 625 1.2× 51 0.3× 61 0.5× 35 0.5× 37 0.9× 5 721
Willy Weng Canada 8 354 0.7× 109 0.6× 237 1.8× 35 0.5× 27 0.6× 17 544
Marcelle D. Smit Netherlands 15 822 1.6× 37 0.2× 66 0.5× 31 0.5× 25 0.6× 30 887

Countries citing papers authored by Gabriel Kamenský

Since Specialization
Citations

This map shows the geographic impact of Gabriel Kamenský's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriel Kamenský with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriel Kamenský more than expected).

Fields of papers citing papers by Gabriel Kamenský

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gabriel Kamenský. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriel Kamenský. The network helps show where Gabriel Kamenský may publish in the future.

Co-authorship network of co-authors of Gabriel Kamenský

This figure shows the co-authorship network connecting the top 25 collaborators of Gabriel Kamenský. A scholar is included among the top collaborators of Gabriel Kamenský based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gabriel Kamenský. Gabriel Kamenský is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Magnani, Giulia, Diego Ardissino, KyungAh Im, et al.. (2021). Predictors, Type, and Impact of Bleeding on the Net Clinical Benefit of Long‐Term Ticagrelor in Stable Patients With Prior Myocardial Infarction. Journal of the American Heart Association. 10(4). e017008–e017008. 17 indexed citations
2.
Furtado, Remo H.M., Ramkumar Venkateswaran, José Carlos Nicolau, et al.. (2020). Caffeinated Beverage Intake, Dyspnea With Ticagrelor, and Cardiovascular Outcomes: Insights From the PEGASUS‐TIMI 54 Trial. Journal of the American Heart Association. 9(10). e015785–e015785. 6 indexed citations
3.
Bonaca, Marc P., Robert F. Storey, Pierre Théroux, et al.. (2017). Efficacy and Safety of Ticagrelor Over Time in Patients With Prior MI in PEGASUS-TIMI 54. Journal of the American College of Cardiology. 70(11). 1368–1375. 52 indexed citations
4.
Bonaca, Marc P., Robert F. Storey, Pierre Théroux, et al.. (2015). Abstract 19642: Consistent Benefit of Ticagrelor Both Early and Late in Patients With Prior MI in PEGASUS-TIMI 54. Circulation. 132(suppl_3). 1 indexed citations
5.
Studenčan, Martin, František Kovář, V. Hricak, et al.. (2014). Two-year survival of STEMI patients in Slovakia. An analysis of the SLOVak registry of Acute Coronary Syndromes (SLOVAKS). Cor et Vasa. 56(4). e297–e303. 1 indexed citations
6.
Kamenský, Gabriel, et al.. (2014). The effect of growth hormone replacement therapy on the morphological and functional changes in the left ventricle in patients with adult-onset growth hormone deficiency. Wiener klinische Wochenschrift. 126(15-16). 480–484. 2 indexed citations
7.
Studenčan, Martin, V. Hricak, František Kovář, et al.. (2011). Implementation of ESC-STEMI guidelines into clinical practice: an analysis of the Slovak Registry of Acute Coronary Syndromes (SLOVAKS). Journal of Cardiovascular Medicine. 12(5). 353–355. 3 indexed citations
8.
Nagarakanti, Rangadham, Michael D. Ezekowitz, Jonas Oldgren, et al.. (2011). Dabigatran Versus Warfarin in Patients With Atrial Fibrillation. Circulation. 123(2). 131–136. 354 indexed citations
9.
McMurray, John J.V., Peter Dunselman, Hans Wedel, et al.. (2010). Coenzyme Q10, Rosuvastatin, and Clinical Outcomes in Heart Failure. Journal of the American College of Cardiology. 56(15). 1196–1204. 82 indexed citations
10.
McMurray, John J.V., John Kjekshus, Lars Gullestad, et al.. (2009). Effects of Statin Therapy According to Plasma High-Sensitivity C-Reactive Protein Concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA). Circulation. 120(22). 2188–2196. 130 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christine Teutsch Breakdown of academic impact, for papers by Chenxi Jiang Breakdown of academic impact, for papers by M. Alasady Breakdown of academic impact, for papers by Étienne Marchand Breakdown of academic impact, for papers by В. А. Марков Breakdown of academic impact, for papers by Xinshun Gu Breakdown of academic impact, for papers by Mikhail S. Dzeshka Breakdown of academic impact, for papers by Michael Stuart Garfinkle Breakdown of academic impact, for papers by Willy Weng Breakdown of academic impact, for papers by Marcelle D. Smit
Rankless by CCL
2026